Strategic and Scientific Advisory Board 

Todd Rosengart, MD

Dr. Todd Rosengart is a nationally recognized cardiothoracic surgeon, a National Institutes of Health (NIH)-supported scientist, and an extensively published investigator.

Since the mid-1980s, Dr. Rosengart’s research group has been working on treatments for heart disease, including angiogenic therapy and, more recently, cellular reprogramming.

Dr. Rosengart is noted for his expertise in minimally invasive heart surgery, minimally invasive valve surgery, off-pump surgery, coronary artery bypass surgery, closure of atrial septal defect (ASD) or ventricular septal defect (VSD), myectomy/myotomy for hypertrophic cardiomyopathy (HCM), minimally invasive aortic or mitral repair or replacement, cardiac surgical procedures, gene therapy, myocardial ischemia and cardiothoracic surgery.

Dr. Rosengart is a professor and chair of Baylor College of Medicine’s Michael E. DeBakey Department of Surgery and the professor of heart and vascular disease at the Texas Heart Institute. He is the appointed DeBakey-Bard Chair of Surgery at Baylor College of Medicine.

Other Team Members

Sylvie Breton

Professor Sylvie Breton, PhD, is a Professor of Medicine at Harvard Medical School, and directs the Breton Laboratory within the Program in Membrane Biology / Center for Systems Biology in the Nephrology Division at the Massachusetts General Hospital.

View bio

Glenn Batchelder

Mr. Glenn Batchelder previously was Co-Founder and CEO of Civitas Therapeutics, a development stage pulmonary delivery therapeutic company based on the ARCUS technology platform that was sold to Acorda Therapeutics.

View bio

John Randle

Dr. John C.R. Randle, PhD, brings over 30 years of practical, hands-on experience to the business of drug candidate selection and development.

View bio

Andrea Franz

Ms. Franz is a financial executive with over 25 years of experience in small to mid-size biotechnology companies.

View bio

Dennis Ausiello, MD

Dennis A. Ausiello, MD, is the Director of the Center for Assessment Technology and Continuous Health (CATCH) at MGH; Jackson Distinguished Professor of Clinical Medicine, Emeritus at Harvard Medical School; and the Physician-in-Chief, Emeritus of the Department of Medicine at MGH.

View bio

Dennis Brown, PhD

Prof. Dennis Brown is an internationally recognized expert on renal physiology and kidney function at the Massachusetts General Hospital (Nephrology Division) and Harvard Medical School.

View bio

Martin Freed, MD

Dr. Martin Freed brings more than 25 years of strategic development and operational expertise from across the biopharmaceutical and life sciences industries.

View bio

Sushrat Waikar, MD, Mph

Sushrut Waikar, MD, MPH, Clinical Advisor, is Associate Professor of Medicine, BWH/HMS. He is Director of Translational Research and Ambulatory Services, BWH and is an expert in acute and chronic kidney disease.

View bio

Winfred W. Williams, MD

Winfred W. Williams, MD, Medical Advisor, is Nephrologist and Associate Chief of the Division of Nephrology at MGH/HMS. He is Director of the Program in Interventional Nephrology for the Transplantation Unit at MGH.

View bio